Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Notes Payables (2016 - 2019)

Fresenius Medical Care AG has reported Notes Payables over the past 11 years, most recently at $1.3 billion for Q4 2019.

  • Quarterly results put Notes Payables at $1.3 billion for Q4 2019, down 7.47% from a year ago — trailing twelve months through Dec 2019 was $1.3 billion (down 7.47% YoY), and the annual figure for FY2019 was $1.3 billion, down 7.47%.
  • Notes Payables for Q4 2019 was $1.3 billion at Fresenius Medical Care AG, down from $1.4 billion in the prior quarter.
  • Over the last five years, Notes Payables for FMCQF hit a ceiling of $1.4 billion in Q4 2018 and a floor of $22000.0 in Q4 2015.
  • Median Notes Payables over the past 5 years was $895.2 million (2017), compared with a mean of $832.3 million.
  • Biggest five-year swings in Notes Payables: plummeted 88.89% in 2015 and later surged 2807231.98% in 2016.
  • Fresenius Medical Care AG's Notes Payables stood at $22000.0 in 2015, then surged by 2807231.98% to $617.6 million in 2016, then surged by 44.94% to $895.2 million in 2017, then soared by 53.68% to $1.4 billion in 2018, then dropped by 7.47% to $1.3 billion in 2019.
  • The last three reported values for Notes Payables were $1.3 billion (Q4 2019), $1.4 billion (Q4 2018), and $895.2 million (Q4 2017) per Business Quant data.